Net Cash Provided by (Used in) Operating Activities |
-20K |
USD |
-14.4% |
Oct 31, 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Financing Activities |
20.1K |
USD |
+16.4% |
Oct 31, 2023 |
Q3 2023 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Common Stock, Shares, Issued |
14M |
shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-68 |
USD |
+70.9% |
Jul 31, 2022 |
Q2 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
514 |
USD |
-6.55% |
Jan 31, 2024 |
Q4 2023 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
350 |
USD |
+23.2% |
Oct 31, 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
165K |
USD |
+6.87% |
Apr 30, 2023 |
Q1 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Oct 31, 2023 |
Q3 2023 |
Deferred Tax Assets, Gross |
175K |
USD |
+7.68% |
Jan 31, 2024 |
Q4 2023 |
Property, Plant and Equipment, Gross |
700 |
USD |
0% |
Jan 31, 2024 |
Q4 2023 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Oct 31, 2023 |
Q3 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
166K |
USD |
+6.81% |
Jan 31, 2024 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Oct 31, 2023 |
Q3 2023 |
Additional Paid in Capital |
433K |
USD |
0% |
Jan 31, 2024 |
Q4 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Jan 31, 2024 |
Q4 2023 |
Interest Expense |
10.4K |
USD |
+2.96% |
Jan 31, 2024 |
Q4 2023 |